GT Medical Technologies, Inc., a company focused on improving the lives of patients with brain tumors, today announced a publication of prospective, multicenter Phase IV data from the ongoing ...
CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke and heart failure. While earlier research pointed to a possible ...
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
News-Medical.Net on MSN
Study reveals long-term health risks after chemotherapy for testicular cancer
A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) ...
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
Shriners Children’s is leading a multi-center study that they hope will improve standards of care for burn patients everywhere and could potentially lead to insurance companies changing their coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results